Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-20
2006-06-20
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S236200, C514S253030, C514S234500, C514S236500, C514S237200, C544S114000, C544S127000, C544S137000, C544S138000, C544S140000, C544S141000, C544S111000
Reexamination Certificate
active
07064123
ABSTRACT:
The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
REFERENCES:
patent: 4927809 (1990-05-01), Stuber et al.
patent: 5424325 (1995-06-01), Ando et al.
patent: 5486623 (1996-01-01), Zimmerman et al.
patent: 5498616 (1996-03-01), Mallano et al.
patent: 5847135 (1998-12-01), Bemis et al.
patent: 5852007 (1998-12-01), Chatterjee et al.
patent: 5874424 (1999-02-01), Batchelor et al.
patent: 5998390 (1999-12-01), Ramamurthy et al.
patent: 6004933 (1999-12-01), Spruce et al.
patent: 6015791 (2000-01-01), Gyorkos et al.
patent: 6022861 (2000-02-01), Scarborough et al.
patent: 6114310 (2000-09-01), Chamberland et al.
patent: 6124333 (2000-09-01), Miller et al.
patent: 6255453 (2001-07-01), Gyorkos
patent: 6353017 (2002-03-01), Altmann et al.
patent: 6455502 (2002-09-01), Bryant et al.
patent: 6476026 (2002-11-01), Bryant et al.
patent: 6492362 (2002-12-01), Graupe et al.
patent: 6506733 (2003-01-01), Buysse et al.
patent: 6576630 (2003-06-01), Link et al.
patent: 6608057 (2003-08-01), Cywin et al.
patent: 0272671 (1988-06-01), None
patent: 0355572 (1990-02-01), None
patent: 0376012 (1990-07-01), None
patent: 0419683 (1991-04-01), None
patent: 0536399 (1993-04-01), None
patent: 0652009 (1995-10-01), None
patent: 0754454 (1997-01-01), None
patent: 0291234 (1998-11-01), None
patent: WO 01/19816 (2001-03-01), None
patent: 42009133 (1967-05-01), None
patent: 63303868 (1988-12-01), None
patent: 06192199 (1994-07-01), None
patent: 2001-011037 (2001-01-01), None
patent: 2001-055366 (2001-02-01), None
patent: WO 95/13069 (1995-05-01), None
patent: WO 95/15309 (1995-06-01), None
patent: WO 95/24382 (1995-09-01), None
patent: WO 96/21655 (1996-07-01), None
patent: WO 96/30353 (1996-10-01), None
patent: WO 96/40647 (1996-12-01), None
patent: WO 96/40744 (1996-12-01), None
patent: WO 96/41638 (1996-12-01), None
patent: WO 97/03679 (1997-02-01), None
patent: WO 98/01133 (1998-01-01), None
patent: WO 98/01428 (1998-01-01), None
patent: WO 98/05336 (1998-02-01), None
patent: WO 98/08802 (1998-03-01), None
patent: WO 98/08867 (1998-03-01), None
patent: WO 98/21188 (1998-05-01), None
patent: WO 98/23588 (1998-06-01), None
patent: WO 98/49190 (1998-11-01), None
patent: WO 99/24460 (1999-05-01), None
patent: WO 00/48992 (2000-08-01), None
patent: WO 00/49007 (2000-08-01), None
patent: WO 00/49008 (2000-08-01), None
patent: WO 00/51998 (2000-09-01), None
patent: WO 00/59881 (2000-10-01), None
patent: WO00/59881 (2000-10-01), None
patent: WO 00/69855 (2000-11-01), None
patent: WO 01/09110 (2001-02-01), None
patent: WO01/09169 (2001-02-01), None
patent: WO 01/19796 (2001-03-01), None
patent: WO 01/19808 (2001-03-01), None
patent: WO 01/30772 (2001-05-01), None
patent: WO 01/55125 (2001-08-01), None
patent: WO 01/58886 (2001-08-01), None
patent: WO02/20485 (2002-03-01), None
patent: WO02/096892 (2002-05-01), None
patent: WO02/057248 (2002-07-01), None
patent: WO02/057249 (2002-07-01), None
patent: WO02/057270 (2002-07-01), None
patent: WO02/100849 (2002-12-01), None
U.S. Appl. No. 10/035,783, filed Dec. 24, 2001, Graupe et al.
U.S. Appl. No. 10/719,080, filed Nov. 21, 2003, Graupe et al.
U.S. Appl. No. 02/17922, filed Nov. 24, 2003, Graupe et al.
U.S. Appl. No. 10/787,367, filed Sep. 16, 2002, Graupe et al.
U.S. Appl. No. 10/418,163, filed Oct. 23, 2003, Li et al.
Adams, et al., Potent and Selective Inhibitors of the Proteasom: Dipeptidyl Boronic Acids, Biooganic & Medicinal Chemistry Letters, 8: 333-338 (1998).
Ashworth, et al, 4-Cyanothiazolidides as very potent, stable inhibitors of dipeptidyl peptidase IV, Bioorganic & Med. Chem. Letters, B,Oxford, 6(22):2745-2748 (1996).
Bergeman, et al., Studies on the reactivity of α-cyanoα-Isocyano alkanoates. Versitile synthons for the assembly of imidazolea, Helv.Chim. ACTA, 62(6):909-918 (1999).
Billson, et al., The Design and Synthesis of Inhibitors of the Cystelnyl, Bioorg. Med. Chem. Lett. vol. 8, pp. 993-998, 1998.
Bromme, et al., Potent Inactivation of Cathepsins S and L, Biol. Chem. Hoppe-Seyler. vol. 375, No. 5, pp. 343-347, 1994.
Chatterjee, et al., D-Amino Acid Containing, High-Affinity Inhibitors of Recombinant Human Calpain I, Journal of Medicinal Chemistry, vol. 41, No. 15, p.: 2663-2666 (1998).
Cohen, et al., Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders, Journal of Neuroimmunology, 98:29-36 (1999).
Dufour, et al., Engineering nitrile hydratase activity into a cysteine protease by a single mutation, Bio.chemistry, US, Am. Chem. Soc., Easton, PA, 34(50):16382-16388 (1995).
Edwards, et al., Design, Synthesis, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors, the Peptidyl a-Ketobenzoxazoles, and the X-ray Crystal Structure of the Covalant Complex between Porcine Pancreatic Elastase and Ac-Ala-Pro-Val-2-Benzoxazole, Journal of American Chemical Society, vol. 114, No. 5, p. 1854-1863 (1992).
Evoli, et al., abstract only, Drugs, 1996, 52(5), 662-70.
Gour-Salin, et al., Inhibition of papain by peptide nitriles: conversion of the nitrile group into other functionalitles via the papain:nitrile thiomidate ester adduct, Can. J. of Chem, CA, National Research Council. Ottawa, 69(8):1288-1297 (1991).
Hallegua, et al., Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature, Lupus, 9:241-251 (2000).
Hanzlik, et al., Reversible covalent binding of peptide nitriles to papain, Biochim. Biophys, Acta, vol. 1035, No. 1, 1990, pp. 62-70.
Harris, et al., Characteristics of a continuous fluorogenic assay for calpain I. Kinetic evaluation of peptide aldehydes, halomethyl ketones and )achalasia) methyl ketones as inhibitors of the enzyme, Chemical Abstracts, 110:7, Bioorg. Med. Chem. Lett, 5(4) 393-398 (1995).
Heitmiller, R.F., abstract only., Semin. Thorac. Cardiovasc. Surg., 1999, 11(1), 41-6.
Katritzky, et al., Benzotriazole-assisted synthesis of α-(acylamino) nitrites and a conceptually novel method for peptide elongation, Chem. Soo., Perkin. Trana. 1(7):1853-1857 (1990).
Khamashta, et al., Expert. Opin. Investig. Drugs, 2000, 9(7), 1581-93.
Krantz, et al., Peptidyl (Acyloxy)methyl Ketones and the Qulescent, Biochemistry. vol. 30, pp. 4878-4687, 1991.
Levy, E.G., Baillieres Clin. Endocrinol. Metab., 1997, 11(3) 585-595.
Li, et al., Aminoacylpyrrolidine-2-nitriles: Potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26), Archives of Biochem. and Bioph., 323(1) 148-154 (1995).
Lipshutz, et al., Chiral Induction in orginally racemic amino adds via 5-acyl and 5-acyloxyaminooxazoles, Isr, J. Chem. 27(1):49-55 (1986), abstract.
Lipshutz, et al., Heterocycles as masked diamide/dipeptide equivalents, Formation and reactions of substituted 5-(acylamino)oxazoles as intermediates en route to the cyclopeptide alkaloids, . Am. Chem. Soc., 105(26):7703-7713 (1983).
Lipshutz et al., Oxazolophanes as masked cyclopeptide alkaloid equivalents: cyclic peptide chemistry without peptides couplings, J. Am. Chem. Soc., 112(19):7032-7041 (1990).
Marquis, et al., Potent dipeptidyketone inhibitors of the cysteine protease cathepsin, Chemical Abstracts. 7:4 581-588 (1999).
McMath, et al., Direct dialkylation of peptide nitriles, Application of the synthesis of 1-aminocyclopropane-1 carboxylic acid (Acc)-containing dipepetides, Bull. Soc. Chim. Fr. 134(1):105-110 (1997).
Moriya, et al., Synthesis and Hypolipidemic Activities of 5-Thienyl-4-oxazoleacetic Acid Derivatives.sup.1, J. Med. Chem., 29:333-341 (1986).
Moser, et al., 130 Poly (dipeptamidinium)-Salze: definition und metoden zur praparatven herstellung, poly (dipeptamidinium) salts: definition and methods of preparation, Helvitica Chimica ACTA, CH, Verlag, Basal 69:1224-1262 (1986).
Nippon, K., Patent Abstracts of Japan, Publication No. 63301868, 013(137)(1988), abstract.
North, et al., Synthetic studies towards cyclic peptides. Concise sythesis of thiazoline and thiazole containing amino acids, Tetrahedron, 48(24):8627-8290 (1990).
Ogilvie, et al., Peptidomimetric Inhi
Aldous David
Graupe Michael
Halley Frank
Li Jiayao
Link John O.
Aventis Pharmaceuticals Inc.
Axys Pharmaceuticals Inc.
Rossi Joseph D.
Shiao Robert
Solola Taofiq
LandOfFree
Compounds and compositions as cathepsin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as cathepsin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as cathepsin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677221